Skip to main content
Rituxan

Rituxan Dosage

Allison Baxley, PharmD, BCOPConnie Zheng, PharmD
Reviewed by Allison Baxley, PharmD, BCOP, Connie Zheng, PharmD
Last reviewed on December 7, 2023

Typical dosage for Rituxan

Blood cancers

Your provider will determine your dose of Rituxan based on your body surface area (BSA) in m². This medication is typically given by a healthcare provider in a hospital or infusion clinic setting. Your provider might also give you other anticancer medications along with Rituxan.

  • Non-Hodgkin’s lymphoma

    • Adults: The typical dose is 375 mg/m² given as an intravenous infusion. How often you’ll receive a dose usually ranges from weekly to every 8 weeks, depending on the type of NHL you have and where you are in the treatment process.
    • Children: Talk with your child’s provider.
  • Chronic Lymphocytic Leukemia (CLL)

    • Adults: The typical dose is to receive one 375 mg/m² intravenous infusion before the start of chemotherapy. Then, your provider will raise your dose to 500 mg/m² infused on Day 1 of a 28-day chemotherapy cycle, for 2 to 6 cycles.

Autoimmune conditions

Your provider might also give you other medications along with Rituxan to treat your condition.

  • RA

    • Adults: The typical starting dose is 1,000 mg infused IV for 2 doses, given 2 weeks apart. The typical maintenance dose is 1,000 mg infused once every 4 to 6 months, depending on your condition.
  • GPA and MPA

    • Adults: Your provider will determine your dose of Rituxan based on your body surface area (BSA) in m². The typical starting dose is 375 mg/m² given as an intravenous infusion weekly for 4 weeks. The typical maintenance dose is 500 mg given as 2 doses 2 weeks apart, then 500 mg every 6 months.
    • Children: Ask your child’s provider.
  • PV

    • Adults: The typical starting dose is 1,000 mg infused IV for 2 doses, given 2 weeks apart. The typical maintenance dose is 500 mg infused a year after the starting dose, then once every 6 months.
GoodRx icon

Other Rituxan articles

Was this page helpful?

Latest articles